Patent · US Active

Inhibitors of human immunodeficiency virus replication

US11958834B2 · kind B2 · utility

0Cited by
1References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 7, 2019
Grant dateApr 16, 2024
Priority date—
Expiry dateJul 15, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.